Evidence map›Paper›PMID 36234988›Full record

ArticleMolecules (Basel, Switzerland)2022

A Cyclen-Functionalized Cobalt-Substituted Sandwich-Type Tungstoarsenate with Versatility in Removal of Methylene Blue and Anti-ROS-Sensitive Tumor Cells.

Jiai Hua, Xueman Wei, Yifeng Li, Lingzhi Li, Hui Zhang, Feng Wang, Changli Zhang, Xiang Ma

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jiai HuaChemistry and Chemical Engineering Department, Taiyuan Institute of Technology, Taiyuan 030008, China.
Xueman WeiDepartment of Geriatrics, First Affiliated Hospital of Naval Medical University, Shanghai 200081, China.
Yifeng LiChemistry and Chemical Engineering Department, Taiyuan Institute of Technology, Taiyuan 030008, China.
Lingzhi LiLaboratory of Biochemistry and Pharmacy, Taiyuan Institute of Technology, Taiyuan 030008, China.
Hui ZhangChemistry and Chemical Engineering Department, Taiyuan Institute of Technology, Taiyuan 030008, China.
Feng WangLaboratory of Biochemistry and Pharmacy, Taiyuan Institute of Technology, Taiyuan 030008, China.
Changli ZhangSchool of Environmental Science, Nanjing Xiaozhuang University, Nanjing 211171, China.
Xiang MaChemistry and Chemical Engineering Department, Taiyuan Institute of Technology, Taiyuan 030008, China.ORCID 0000-0001-7679-5741
Taiyuan Institute of Technology · CNNanjing Xiaozhuang University · CN

Funding

Research Foundation of the Chinese State Key Laboratory of Coordination Chemistry SKLCC202204Scientific and Technologial Innovation Programs of Higher Education Institutions in Shanxi STIP 2020L0643 and 2020L0644Shanxi Province Science Foundation for Youths 201901D211453 and 20210302124333
6 · The paper itself

Abstract

Oxidative degradation by using reactive oxygen species (ROS) is an effective method to treat pollutants. The synthesis of artificial oxidase for the degradation of dyes is a hot spot in molecular science. In this study, a nanoscale sandwich-type polyoxometalate (POM) on the basis of a tetra-nuclear cobalt cluster and trivacant B-

Indexed as

CyclamsEnvironmental PollutantsAnionsArsenatesCobaltColoring AgentsMethylene BlueOxidoreductasesPolyelectrolytesPolyoxometalatesReactive Oxygen SpeciesTungsten CompoundsAnionsArsenatesCobaltColoring AgentsCyclamscyclenEnvironmental PollutantsMethylene BlueOxidoreductasesPolyelectrolytesPolyoxometalatesReactive Oxygen SpeciesTungsten Compoundstungstoarsenateartificial oxidasemethylene blue dyesnanoscale catalystreactive oxygen speciessandwich-type arsenomolybdate

Identifiers

PMID36234988
PMCPMC9573041
OpenAlexW4303857026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.